Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Neoplasms 2Colorectal Neoplasms 2Uveal Melanoma 1Rare Tumor 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Crizotinib × Clear all
NCT03947385 2026-01-27

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

IDEAYA Biosciences

Phase 1/2 Recruiting
336 enrolled
DermatologicGastrointestinal

Uveal Melanoma, Melanoma, Colorectal Neoplasms

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡